Global Tizanidine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Tizanidine Market Research Report 2024
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
According to Mr Accuracy reports new survey, global Tizanidine market is projected to reach US$ 530.7 million in 2029, increasing from US$ 360 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tizanidine market research.
Key manufacturers engaged in the Tizanidine industry include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma and Dr. Reddy's Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tizanidine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tizanidine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tizanidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
Segment by Type
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Kids
Adults
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tizanidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Tizanidine market is projected to reach US$ 530.7 million in 2029, increasing from US$ 360 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tizanidine market research.
Key manufacturers engaged in the Tizanidine industry include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma and Dr. Reddy's Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tizanidine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tizanidine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tizanidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
Segment by Type
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Segment by Application
Kids
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tizanidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
